摘要
炎症性肠病（IBD）是一类病因不明的慢性非特异性肠道炎症性疾病,包括溃疡性结肠炎（UC）和克罗恩病（CD）.IL是一大类具有多种生物活性的细胞因子,对免疫细胞的发育、分化、免疫等起着关键的作用.随着国内外对IBD发病机制的研究日益深入,部分IL被发现并证明在IBD发生、发展过程中发挥着重要作用,并且成为IBD诊疗研究的新热点.
Inflammatory bowel disease （IBD） is a group of chronic and non-specific intestinal inflammatory diseases of undetermined origin,which including ulcerative colitis （UC） and crohn＆#39;s disease （CD）.Interleukin（IL） is a kind of cytokines,and plays an vital role in growth,differentiation,immune response of immune cell.With a intensive study in the pathogenesis of IBD in the world,parts of IL were found and confirmed to be a important role in the progression of IBD,and will become a new hot spot in the research of the diagnosis and treatment of IBD.
出处
《中国综合临床》
2017年第6期572-576,共5页
Clinical Medicine of China
